Item 1.01 Entry into a Material Definitive Agreement

Agreement and Plan of Merger

On June 23, 2022, Radius Health, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Ginger Acquisition, Inc., a Delaware corporation ("Parent"), a subsidiary jointly owned by Gurnet Point Capital, LLC and Patient Square Capital, and Ginger Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

Pursuant to the Merger Agreement, and upon the terms and subject to the conditions thereof, Purchaser will commence a tender offer (the "Offer") to purchase each issued and outstanding share (the "Shares") of common stock, par value $0.0001 per share, of the Company (the "Common Stock") in exchange for (x) an amount in cash equal to $10.00, without interest and less applicable tax withholdings (the "Cash Consideration"), and (y) one contractual contingent value right (a "CVR") that will represent the right to receive a contingent payment of $1.00 (without interest thereon) upon the achievement of certain conditions described under the "Contingent Value Right Agreement" section below, pursuant to a Contingent Value Rights Agreement (the "CVR Agreement") to be entered into between Parent and a rights agent mutually agreeable to Parent and the Company (the "Rights Agent") (the Cash Consideration and one CVR, collectively, the "Offer Price"). Subject to the terms and conditions of the Merger Agreement, if certain conditions are satisfied and the Offer closes, Parent would acquire any remaining shares in connection with a merger of Purchaser with and into the Company (the "Merger"), with the Company being the surviving corporation. The Merger Agreement contemplates that the Merger will be effected pursuant to Section 251(h) of the General Corporation Law of the State of Delaware (the "DGCL"), which permits completion of the Merger without a stockholder vote promptly following consummation of the Offer.

At the effective time of the Merger (the "Effective Time"), each:



    1)   Share issued and outstanding immediately prior to the Effective Time
         (other than (i) each Share held in the treasury of the Company or owned
         by the Company or any direct or indirect wholly owned subsidiary of the
         Company and each Share owned by Parent, Purchaser or any direct or
         indirect wholly owned subsidiary of Parent or Purchaser immediately prior
         to the Effective Time or (ii) Shares outstanding immediately prior to the
         Effective Time and held by stockholders who are entitled to demand, and
         properly demand, appraisal for such Shares in accordance with Section 262
         of the DGCL) will be converted into the right to receive the Offer Price,
         without interest (the "Merger Consideration");



    2)   (i) Company stock option ("Company Stock Option"), Company restricted
         stock unit ("Company RSU") and Company performance stock unit ("Company
         PSU" and, together with the Company RSUs, the "Company Equity Awards")
         that is outstanding and unvested immediately prior to the Effective Time
         that vests solely based on the holder's continued employment or service,
         will vest in full, and (ii) Company Stock Option and Company Equity Award
         that does not vest solely based on the holder's continued employment or
         service, will vest (in part or in full) based on achievement of the
         specified performance in accordance with the terms and conditions of the
         Company Stock Option or Company Equity Award, as applicable, and the
         terms of the Merger Agreement and the unvested portion of each such award
         will be cancelled for no consideration;



    3)   (i) Company Stock Option that has an exercise price per Share that is
         less than the Offer Price (an "In-the-Money Option") that is outstanding
         will be cancelled, and, in exchange therefor, the holder of such
         cancelled Company Stock Option will be entitled to receive (without
         interest), (A) an amount in cash (less applicable tax withholdings) equal
         to the product of (x) the total number of Shares subject to such Company
         Stock Option immediately prior to the Effective Time multiplied by
         (y) the excess, if any, of the Cash Consideration over the applicable
         exercise price per Share under such Company Stock Option, and (B) one CVR
         for each Share subject thereto (the "Option Consideration"), and
         (ii) each Company Stock Option that is not an In-

--------------------------------------------------------------------------------


        the-Money Option will be cancelled for no consideration. As of the
        Effective Time, all holders of Company Stock Options will cease to have
        any rights with respect thereto, except the right to receive the Option
        Consideration in accordance with the Merger Agreement; and



    4)   Company Equity Award that is outstanding will be cancelled, and the
         holder of such cancelled Company Equity Award will be entitled, in
         exchange therefor, to receive (without interest) (A) an amount in cash
         (less applicable tax withholdings) equal to the product of (x) the total
         number of Shares subject to (or deliverable under) such Company Equity
         Award immediately prior to the Effective Time multiplied by (y) the Cash
         Consideration, and (B) one CVR for each Share subject thereto.

Consummation of the Offer is subject to certain conditions, including: (i) immediately prior to the expiration of the Offer (as extended in accordance with the Merger Agreement) the number of Shares validly tendered, and not validly withdrawn, is at least one more than 50% of the total number of Shares outstanding at the time of the expiration of the Offer (the "Minimum Condition"); (ii) immediately prior to the expiration of the Offer (as extended in accordance with the Merger Agreement), any waiting period (and any extensions thereof) and any approvals or clearances applicable to the consummation of the transactions contemplated by the Merger Agreement in accordance with the Hart-Scott-Rodino Antitrust Improvements Act of 1976 have expired or been terminated or obtained, as applicable; and (iii) none of the following events shall have occurred and be continuing: (a) there is pending any suit, action or proceeding by a governmental body (i) seeking to prohibit or impose any material limitations on Parent's or Purchaser's ownership or operation of all or any material portion of their or the Company's businesses or assets, taken as a whole, or to compel Parent or Purchaser to dispose of or hold separate any material portion of the business or assets of the Company or Parent, (ii) seeking to prohibit or make illegal the making or consummation of the Offer or the Merger, (iii) seeking to impose material limitations on the ability of Purchaser, or render Purchaser unable, to accept for payment, pay for or purchase Shares in accordance with the Offer or the Merger such that the Minimum Condition would fail to be satisfied or (iv) seeking to impose material limitations on the ability of Purchaser or Parent effectively to exercise full rights of ownership of the Shares; (b) there is any statute, rule, regulation, judgment, order or injunction enforced, by or on behalf of a governmental body, to the Offer, the Merger or any other transaction contemplated by the Merger Agreement, or any other action will be taken by any governmental body, that is reasonably expected to result, directly or indirectly, in any of the consequences referenced in clauses (i) through (iv) of (a) above; (c) subject to certain qualifications, the accuracy of representations and warranties of the Company under the Merger Agreement, (d) the performance and compliance in all material respects by the Company of its obligations under the Merger Agreement; (e) the absence of any Company Material Adverse Effect (as defined in the Merger Agreement); (f) the delivery by the Company to Parent of a certificate signed by an authorized officer of the Company certifying as to the satisfaction of certain closing conditions by Company. The Minimum Condition may not be waived by Parent or Purchaser without the prior written consent of the Company.

Consummation of the Merger is subject to certain conditions, including: (i) no order, injunction or decree issued by any court or other governmental body, and no statute, rule, regulation, order, injunction, or decree will have been enacted, entered, promulgated, or enforced (and continue to be in effect) by any governmental body that prohibits, enjoins, restricts, prevents or makes illegal the consummation of the transactions contemplated by the Merger Agreement; and (ii) Purchaser has irrevocably accepted for purchase the Shares validly tendered (and not validly withdrawn) pursuant to the Offer.

The Company has made customary representations and warranties in the Merger Agreement and has agreed to customary covenants regarding the operation of the business of the Company and its subsidiaries to the Effective Time.

The Merger Agreement also includes covenants requiring the Company not to (i) initiate, solicit, knowingly encourage or knowingly facilitate any inquiry with respect to, or the making, submission or announcement of any alternative acquisition proposal, (ii) enter into, continue or engage in negotiations with any person (other than Parent or Purchaser, or any of their designees) with respect to any alternative acquisition proposal or any inquiry or proposal that could reasonably be expected to lead to an alternative acquisition proposal, (iii) provide any non-public information or access to any person (other than Parent or Purchaser, or any of their designees) in connection with any alternative acquisition proposal or any inquiry or proposal that could reasonably be expected to lead to an alternative acquisition proposal, (iv) approve, endorse or recommend any alternative acquisition proposal, or any person becoming an "interested stockholder" of the Company as defined in Section 203 of the DGCL, (v) enter into any letter of intent or agreement in principle or any agreement providing for any alternative acquisition proposal (except for confidentiality agreements permitted under the Merger Agreement) or (vi) to resolve to do or agree or publicly announce an intention to do any of the foregoing.

--------------------------------------------------------------------------------

Notwithstanding these restrictions, the Company may under certain circumstances provide information to and engage in discussions or negotiations with third parties with respect to a bona fide acquisition proposal that Company's Board of Directors (the "Company Board") determines in good faith, after consultation with the Company's financial advisors and outside legal counsel, constitutes a Superior Proposal (as defined in the Merger Agreement). In addition, the Company Board is permitted, subject to the terms and conditions set forth in the Merger Agreement, to make a Change of Board Recommendation (as defined in the Merger Agreement) following (i) receipt of a Superior Proposal that did not result from a material breach of the non-solicitation covenants in the Merger Agreement, or (ii) in response to an Intervening Event (as defined in the Merger Agreement), in each case, if the Company Board concludes in good faith, after consultation with outside counsel and its financial advisors, that failure to take such action would reasonably be likely to be inconsistent with the directors' fiduciary duties under applicable law and subject to certain matching rights in favor of Parent.

The Merger Agreement contains certain termination rights for each of the Company and Parent. Upon termination of the Merger Agreement by the Company in accordance with its terms, under certain circumstances, the Company will be required to pay Parent a termination fee in an amount equal to $16.15 million, including if the Merger Agreement is terminated due to (i) the Company Board accepting a Superior Proposal or (ii) the Company Board or any committee thereof effecting a Change of Board Recommendation. This termination fee will also be payable by the Company if the Merger Agreement is terminated under certain circumstances and prior to such termination, an Acquisition Proposal is publicly disclosed and not publicly withdrawn and the Company enters into an Alternate Acquisition Agreement within 12 months of such termination and such Acquisition Proposal is subsequently consummated. Additionally, upon termination of the Merger Agreement by Parent in accordance with its terms, under certain circumstances, Parent will be required to pay the Company a termination fee in an amount equal to $22.64 million, including if the Company has satisfied the closing conditions required under the Merger Agreement and Parent and Purchaser fail to consummate the closing of the transactions contemplated by the Merger Agreement. In addition, in the event that the Merger Agreement is terminated by either Parent or the Company due to a failure to reach the Minimum Condition in the Offer, the Company will pay to Parent a reimbursement payment for fees and expenses incurred in connection with the Merger Agreement and the transactions contemplated thereby in an amount not to exceed $3.5 million.

Concurrently with the execution of the Merger Agreement, each of GPC WH Fund LP and Patient Square Equity Partners, LP (together, the "Guarantors") entered into a limited guarantee (together, the "Limited Guarantees") in favor of the Company, pursuant to which the Guarantors have each provided a limited guarantee with respect to the payment of their pro rata portion of the termination fee payable by Parent, as well as certain reimbursement and indemnity obligations that may be owed by Parent pursuant to the Merger Agreement, in each case, subject to the terms of the Merger Agreement and of such Limited Guarantee.

Concurrently with the execution of the Merger Agreement, each of the Guarantors entered into an equity commitment letter (together, the "Equity Commitment Letters") with Parent, pursuant to which the Guarantors agreed to provide equity commitments to Parent in an aggregate amount of $496.0 million to finance the transactions contemplated by the Merger Agreement and to pay related fees and expenses.

Concurrently with the execution of the Merger Agreement, Parent entered into a debt commitment letter dated June 23, 2022 (the "Debt Commitment Letter"), . . .

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits

Exhibit
Number                                Exhibit Description

2.1*           Agreement and Plan of Merger, dated as of June 23, 2022, by and
             among the Company, Ginger Acquisition, Inc. and Ginger Merger Sub,
             Inc.

10.1           Form of Contingent Value Rights Agreement to be entered into between
             Ginger Acquisition, Inc. and a Rights Agent

--------------------------------------------------------------------------------



99.1           Press Release, dated as of June 23, 2022

104          The cover page of this Current Report on Form 8-K formatted as Inline XBRL


* Certain exhibits and schedules have been omitted pursuant to Item 601(b)(2) of

Regulation S-K. The Company agrees to furnish supplementally to the SEC a copy

of any omitted exhibits or schedules upon request.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses